Multiple myeloma treatment patterns and clinical outcomes in the Latin America Haemato‐Oncology (HOLA) Observational Study, 2008–2016 - Hungria, Vania Tietsche; Martínez‐Baños, Deborah M.; Peñafiel, Christian R.; Miguel, Carlos E.; Vela‐Ojeda, Jorge; Remaggi, Guillermina; Duarte, Fernando B.; Cao, Carmen; Cugliari, Maria S.; Santos, Telma; Machnicki, Gerardo; Fernandez, Mariana; et al. (British journal of haematology, 2020)
Keywords: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Autografts; Bortezomib; Bortezomib - administration & dosage; Chemotherapy; Clinical outcomes; Comorbidity; Drug Utilization - statistics & numerical data; epidemiology; Female; Follow-Up Studies; Haematological Malignancy ‐ Clinical; Hematology; Hematopoietic Stem Cell Transplantation - statistics & numerical data; Humans; Kaplan-Meier Estimate; Latin America; Latin America - epidemiology; Male; Medical records; Middle Aged; Multiple myeloma; Multiple Myeloma - epidemiology; Multiple Myeloma - therapy; Observational studies; Oncology; Patients; Practice Patterns, Physicians' - statistics & numerical data; Private Facilities - statistics & numerical data; progression‐free survival; Public Facilities - statistics & numerical data; Research Paper; Retrospective Studies; Stem cell transplantation; Thalidomide; Thalidomide - administration & dosage; Treatment Outcome; treatment patterns; Latin America; epidemiology; multiple myeloma; progression-free survival; treatment patterns; Latin America